Baader Bank Aktiengesellschaft’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-210,098
Closed -$3.41M – 538
2024
Q2
$3.41M Buy
210,098
+76,909
+58% +$1.18M 0.22% 110
2024
Q1
$1.88M Buy
133,189
+101,128
+315% +$1.27M 0.13% 113
2023
Q4
$335K Buy
+32,061
New +$299K 0.02% 253

Other funds holding TEVA

Baader Bank Aktiengesellschaft's TEVA Position: Q3 2024 in Review

Baader Bank Aktiengesellschaft sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2024, closing a stake of 210,098 shares — an estimated $3.41M sold.

Baader Bank Aktiengesellschaft first reported a position in TEVA in Q4 2023 and held it in 3 quarters. The position peaked at $3.41M in Q2 2024. 543 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • Baader Bank Aktiengesellschaft reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2024 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 210,098 Teva Pharmaceutical Industries Limited shares in Q3 2024, an estimated $3.41M.
  • Baader Bank Aktiengesellschaft first reported a position in Teva Pharmaceutical Industries Limited in Q4 2023 and held it in 3 quarters.
  • Baader Bank Aktiengesellschaft's Teva Pharmaceutical Industries Limited position peaked at $3.41M in Q2 2024.
  • 543 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2024.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q3 2024, filed 29 Oct 2024.